Our published results confirmed that TAGLN expression increased in HBV-positive hepatocellular carcinoma tissues and cells compared with HBV-negative hepatocellular carcinoma, and interference with TAGLN expression can inhibit the proliferation of HepG2.2.15 cells and weaken their ability of migration and invasion17. Here, TAGLN is linked to hepatocellular carcinoma.